B7-H3, an immunoregulatory protein, was found to confer resistance to oxaliplatin and 5-FU in colorectal cancer cell lines through upregulation of hexokinase 2 (HK2) leading to increased glucose and lactate consumption (Shi et al., 2019). Here, HK2 is linked to colorectal cancer.